211 related articles for article (PubMed ID: 16524795)
21. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
[TBL] [Abstract][Full Text] [Related]
23. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial.
Serruys PW; Degertekin M; Tanabe K; Russell ME; Guagliumi G; Webb J; Hamburger J; Rutsch W; Kaiser C; Whitbourn R; Camenzind E; Meredith I; Reeves F; Nienaber C; Benit E; Disco C; Koglin J; Colombo A;
Circulation; 2004 Feb; 109(5):627-33. PubMed ID: 14769685
[TBL] [Abstract][Full Text] [Related]
24. Intimal proliferation and restenosis in paclitaxel-eluting stents with aminoparylene as carrier substance in swines.
Flueckiger A; Strahm Y; Billinger M; Meier P; Mettler D; Studer U; Schaffner T; Hess OM
J Invasive Cardiol; 2009 Mar; 21(3):128-32. PubMed ID: 19258644
[TBL] [Abstract][Full Text] [Related]
25. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
26. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
[TBL] [Abstract][Full Text] [Related]
27. The impact of IVUS guided bare metal stent implantation for non-small vessel.
Kataoka T; Shimada K; Fukuda D; Nishioka H; Oda S; Ehara S; Hirose M; Kamimori K; Kobayashi Y; Yoshiyama M; Takeuchi K; Yoshikawa J
Osaka City Med J; 2004 Dec; 50(2):79-86. PubMed ID: 15819302
[TBL] [Abstract][Full Text] [Related]
28. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
[TBL] [Abstract][Full Text] [Related]
29. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
[TBL] [Abstract][Full Text] [Related]
30. Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial).
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ;
Am J Cardiol; 2007 Oct; 100(7):1103-8. PubMed ID: 17884371
[TBL] [Abstract][Full Text] [Related]
31. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.
Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW
Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.
Gershlick A; De Scheerder I; Chevalier B; Stephens-Lloyd A; Camenzind E; Vrints C; Reifart N; Missault L; Goy JJ; Brinker JA; Raizner AE; Urban P; Heldman AW
Circulation; 2004 Feb; 109(4):487-93. PubMed ID: 14744971
[TBL] [Abstract][Full Text] [Related]
34. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
[TBL] [Abstract][Full Text] [Related]
35. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial.
Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW
Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664
[TBL] [Abstract][Full Text] [Related]
36. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
[TBL] [Abstract][Full Text] [Related]
37. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis.
Lim SY; Jeong MH; Hong SJ; Lim DS; Moon JY; Hong YJ; Kim JH; Ahn Y; Kang JC
Circ J; 2008 Mar; 72(3):463-8. PubMed ID: 18296847
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
[TBL] [Abstract][Full Text] [Related]
39. The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
Akbulut M; Ozbay Y; Karaca I; Ilkay E; Gundogdu O; Arslan N
Coron Artery Dis; 2004 Sep; 15(6):347-52. PubMed ID: 15346093
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
